Windlas Biotech Limited IPO
BSE, NSEClosed
Aug 4, 2021Open Date
Aug 6, 2021Close Date
TBAAllotment Date
Aug 16, 2021Listing Date
Subscription Details
View Subscription DetailsQIB24.10x
Retail24.27x
NIIs (Non-Institutional Investors)Main Category
15.91xOverall Subscription
Total Bids Received
22.47x
Updated: 10 Jul, 06:09 pm
Windlas Biotech Limited IPO Issue Details
Issue Price₹448-460 Per Equity Share
Face Value₹5 Per Equity Share
Listing AtBSE, NSE
Listing DateAug 16, 2021
Company Information
Windlas Biotech Ltd is one of the leading companies in the pharmaceutical formulations contract development and manufacturing organizations (CDMO) segment in India. The company offers a range of CDMO ...
Valuations
RoNW
18.19%
Financial Information (₹ in Crores)
| Metric | FY 21 | FY 20 | FY 19 | FY 18 |
|---|---|---|---|---|
| Total Assets | 296.12 | 338.48 | 198.18 | 298.88 |
| Total Revenue | 430.69 | 331.33 | 311.52 | 356.57 |
| Profit After Tax | 15.57 | 16.21 | 63.82 | 11.19 |
| Net Worth |
* All figures are in ₹ Crores unless otherwise stated.
Objectives of the Issue
- 1Purchase of equipment required for (i) capacity expansion of our existing facility at Dehradun Plant – IV; and (ii) addition of injectables dosage capability at our existing facility at Dehradun Plant-II;
- 2General Corporate Purpose
- 3To meet issue expenses
- 4Repayment/prepayment of certain of our borrowings
Windlas Biotech Limited – Promoter(s)
Ashok Kumar Windlass
Hitesh Windlass
Manoj Kumar Windlass
AKW WBL Family Pvt Trust
Contact Details
Frequently Asked Questions — Windlas Biotech Limited IPO
Download Mobile App
Get push notifications instantly when IPO allotment goes live!
Angel One
Free DematZero Brokerage Equity
Zerodha
Free DematIndia's #1 Stock Broker
Upstox
Free DematInstant Demat Account
